Compared to the GLP-1 receptor agonist semaglutide and placebo, tirzepatide demonstrated superior reductions in HbA1c (2.05%) and body weight (11.2kg) over 28 weeks
At present: There is no strong evidence that GLP-1 receptor agonists directly cause universal micronutrient deficiency
Biosimilar development costs $100-300 million per product, takes 5-9 years, and requires a cell line, manufacturing process, and comparability data set built entirely independent of the originator
Neinstein said the surgery lasts three to four hours, and patients stay overnight for monitoring
Grip strength and five-repetition maximum in compound lifts offer additional functional metrics that capture the muscular benefits of improved mitochondrial efficiency and glucose uptake in skeletal muscle
Oxidative stress is a major factor that leads to cell aging